This webinar explored ertugliflozin as a treatment for equine hyperinsulinemia, using real-world case examples and emerging evidence. It addressed patient selection, treatment and monitoring strategies, and practical considerations for applying research to everyday clinical care in horses at risk of metabolic disease and laminitis.
